Advertisement
Screener

Glucotrack, Inc. (GCTK) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances

2.8 / 5 stars · 68/120 Roast Me

Glucotrack, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances

Glucotrack, Inc. (GCTK) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $347.89 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.

Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2018-11-14

  • Glucotrack, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2018-09-30 was $168.66K, a 96.11% increase year-over-year.
  • Glucotrack, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2018-06-30 was $53.63K, a 54.13% decline year-over-year.
  • Glucotrack, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2018-03-31 was $125.60K, a 19.87% decline year-over-year.
  • Glucotrack, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2017-09-30 was $86.00K, a 78.38% increase year-over-year.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month
2018-09-30$168.66K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$222.29K
derived: sum of 2 quarters · filed 2018-11-14
$347.89K
10-Q · filed 2018-11-14
2018-06-30$53.63K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$179.23K
10-Q · filed 2018-08-14
2018-03-31$125.60K
10-Q · filed 2018-05-15
2017-09-30$86.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$202.92K
derived: sum of 2 quarters · filed 2018-11-14
$359.65K
10-Q · filed 2018-11-14
2017-06-30$116.92K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$273.65K
10-Q · filed 2018-08-14
2017-03-31$156.73K
10-Q · filed 2018-05-15
2016-09-30$48.21K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$282.22K
10-Q · filed 2017-11-14
2016-06-30$234.01K
10-Q · filed 2017-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACCURAY INC (ARAY)United States$0.027B-0.63
PAVmed Inc. (PAVM)United States$0.031B-3.00
InspireMD, Inc. (NSPR)$0.033B
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47